Innovative Approaches to Malignant SBO Research Grant in loving memory of Irina Rozentsveyg funds researchers developing ways to prevent or relieve bowel obstruction in advanced ovarian cancer and enable cancer treatment.
Funder: Foundation for Women's Cancer
Due Dates: October 7, 2026 (LOI) | December 9, 2026 (Invited full proposal) | February 9, 2027 (Award notification) | March 19–22, 2027 (Award presentation)
Funding Amounts: $100,000 for one year
Summary: Supports innovative research to prevent or relieve malignant bowel obstruction in advanced ovarian cancer and enable continued cancer treatment.
Key Information: Research must take place in the United States; non-SGO applicants need an SGO-member co-investigator or sponsor.
The Foundation for Women's Cancer (FWC) offers this grant in memory of Irina Rozentsveyg to improve outcomes for patients with advanced ovarian cancer complicated by malignant bowel obstruction. It supports therapeutic, procedural, supportive-care, and multidisciplinary strategies that prevent or relieve obstruction, particularly approaches enabling patients to continue or resume effective cancer-directed treatment.
Projects may involve laboratory, computational, engineering, preclinical, or early translational research. Areas of interest include surgical or minimally invasive approaches; stents, devices, biomaterials, and drug-delivery systems; management of partial obstruction; prevention of progression; and preservation of bowel function, nutrition, and quality of life. Research into obstruction biology is encouraged when it could identify direct prevention or management targets, including mechanisms involving peritoneal disease, fibrosis, and intestinal dysfunction. Multidisciplinary proposals may draw on gynecologic oncology, surgery, gastroenterology, interventional radiology, biomechanics, biomedical engineering, materials science, and related fields.